L001: === CHART: Orthopedic Consultation Note ===
L002: 
L003: [AI ADDED: Header information organized]
L004: Date of Service: 12/29/2025
L005: Patient: Renke Thye
L006: MRN: MR364652
L007: DOB: 7/30/1938 (87 years old)
L008: Provider: Michael B Held, MD
L009: Service: Orthopedics
L010: 
L011: [AI ADDED: Section header] REASON FOR CONSULTATION
L012: Left hip fracture
L013: 
L014: [AI ADDED: Section header] HISTORY OF PRESENT ILLNESS
L015: Renke B Thye is an 87-year-old male with past medical history of hypertension, hyperlipidemia, GERD, coronary artery disease status post stents in 2015, and history of left subarachnoid hemorrhage who presents status post mechanical fall with left hip pain and inability to ambulate. At baseline, the patient ambulates unassisted and lives with his wife. He is still very active, walking 5000 steps per day. Patient denies any antecedent left hip pain. Denies head strike or loss of consciousness. No other pain or injury except his left hip.
L016: 
L017: [AI ADDED: Section header] SOCIAL HISTORY
L018: Patient reports that he has quit smoking. He has never used smokeless tobacco. He reports current alcohol use [⚠️ PHYSICIAN INPUT REQUIRED: frequency and amount of alcohol consumption]. He reports that he does not use drugs.
L019: 
L020: [AI ADDED: Section header] PAST MEDICAL HISTORY
L021: - Chronic coronary artery disease
L022: - GERD (gastroesophageal reflux disease)
L023: - Hypercholesterolemia
L024: - Hypertension
L025: - Stroke - atraumatic right cortical subarachnoid hemorrhage (05/11/2025)
L026: 
L027: [AI ADDED: Section header] PAST SURGICAL HISTORY
L028: - Coronary stent placement (2 stents per patient)
L029: - Bilateral knee joint replacement
L030: - Laparoscopic cholecystectomy
L031: 
L032: [AI ADDED: Section header] MEDICATIONS
L033: [AI ADDED: Simplified medication list]
L034: - Acetaminophen (Tylenol) 975 mg oral Q6H
L035: - Amlodipine (Norvasc) 5 mg oral daily
L036: - Bisacodyl (Dulcolax) 5 mg oral daily PRN
L037: - Bisacodyl (Dulcolax) 10 mg rectal daily PRN
L038: - Chlorhexidine gluconate 2% towelette topical once PRN
L039: - Divalproex (Depakote DR) 500 mg oral BID
L040: - Fentanyl (Sublimaze) 50 mcg IV push Q5 min PRN
L041: - Hydromorphone (Dilaudid) 0.5 mg IV push Q4H PRN
L042: - Hydromorphone (Dilaudid) 1 mg IV push Q4H PRN
L043: - Memantine (Namenda) 10 mg oral Q12H
L044: - Midazolam (Versed) 2 mg IV push Q5 min PRN
L045: - Ondansetron (Zofran) 4 mg IV push Q6H PRN
L046: - Ondansetron (Zofran-ODT) 4 mg translingual Q6H PRN
L047: - Oxycodone (Roxicodone) 10 mg oral Q3H PRN
L048: - Oxycodone (Roxicodone) 15 mg oral Q3H PRN
L049: - Oxycodone (Roxicodone) 5 mg oral Q3H PRN (start on 12/30/2025)
L050: - Polyethylene glycol (Miralax) 17 g oral daily
L051: - Povidone-iodine 5% nasal swab once
L052: - Rosuvastatin (Crestor) 10 mg oral daily
L053: - Senna (Senokot) 17.2 mg (2 tablets) oral nightly (start on 12/30/2025)
L054: - Sodium chloride 0.9% flush 3 mL IV push Q8H
L055: - Sodium chloride 0.9% flush 3 mL IV push PRN for line care
L056: - Sodium chloride 0.9% infusion 75 mL/hr continuous
L057: 
L058: [AI ADDED: Section header] ALLERGIES
L059: Patient has no known allergies.
L060: 
L061: [AI ADDED: Section header] PHYSICAL EXAMINATION
L062: [AI ADDED: Vital signs organized]
L063: Temperature: 98°F (36.7°C)
L064: Pulse: 64 bpm
L065: Respiratory Rate: 19 breaths/min
L066: Blood Pressure: 162/66 mmHg
L067: SpO2: 94%
L068: 
L069: [AI ADDED: Organized examination findings]
L070: General: Awake, alert, no acute distress
L071: Cardiovascular: Regular heart rate
L072: Respiratory: Unlabored breathing
L073: 
L074: Left Lower Extremity:
L075: - Skin intact, leg shortened/externally rotated
L076: - Intact ankle dorsiflexion, plantar flexion, extensor hallucis longus function
L077: - Sensation intact grossly in superficial peroneal, deep peroneal, and tibial nerve distributions
L078: - Toes warm, well-perfused with palpable dorsalis pedis pulse
L079: - Nonpainful left knee/ankle range of motion
L080: 
L081: Pelvis: No pain or instability with anteroposterior or lateral compression
L082: All other large joints in the extremities were palpated and ranged with no signs of deformity or pain.
L083: 
L084: [AI ADDED: Section header] IMAGING/STUDIES
L085: XR AP pelvis + femur demonstrates left displaced femoral neck hip fracture
L086: 
L087: [AI ADDED: Section header] ASSESSMENT
L088: Renke B Thye is an 87-year-old male who sustained a left displaced femoral neck fracture. Femur fractures in the elderly are of the highest severity due to the morbidity without treatment and risk of death due to bed-ridden disability, risk of [⚠️ PHYSICIAN INPUT REQUIRED: complete the assessment regarding specific risks for this patient].
L089: 
L090: [AI ADDED: Section header] PLAN
L091: [⚠️ PHYSICIAN INPUT REQUIRED: Specific surgical plan details including procedure type (hemiarthroplasty vs. total hip arthroplasty), approach, and timing]
L092: 
L093: [AI ADDED: Medical necessity documentation] MEDICAL NECESSITY DOCUMENTATION:
L094: . Diagnosis: Left displaced femoral neck fracture
L095: . Functional status: Patient was independent and active prior to injury (walking 5000 steps daily)
L096: . Failed conservative measures: [⚠️ PHYSICIAN INPUT REQUIRED: Document any attempted conservative measures or rationale for proceeding directly to surgery]
L097: . Surgical indication: Displaced femoral neck fracture in elderly patient with high pre-injury functional status
L098: . Expected outcome: [⚠️ PHYSICIAN INPUT REQUIRED: Document expected functional outcomes and goals of surgery]
L099: 
L100: [AI ADDED: Informed consent documentation] INFORMED CONSENT:
L101: Had a long discussion with the patient and their family about the treatment options, including nonoperative and operative intervention. We discussed risks and benefits and alternatives to surgery as well as chances of full [⚠️ PHYSICIAN INPUT REQUIRED: complete the informed consent documentation including specific risks discussed and patient's understanding].
L102: 
L103: [AI ADDED: Signature block]
L104: Michael B Held, MD
L105: Orthopedics
L106: Date: 12/29/2025